Inactivation of microorganisms within collagen gel biomatrices using pulsed electric field treatment

被引:0
作者
Sarah Griffiths
Michelle Maclean
John G. Anderson
Scott J. MacGregor
M. Helen Grant
机构
[1] University of Strathclyde,Bioengineering Unit
[2] University of Strathclyde,Department of Electronic and Electrical Engineering, The Robertson Trust Laboratory for Electronic Sterilisation Technologies
来源
Journal of Materials Science: Materials in Medicine | 2012年 / 23卷
关键词
Pulse Electric Field; Pulse Number; Inactivation Rate; Pulse Electric Field Treatment; Microbial Inactivation;
D O I
暂无
中图分类号
学科分类号
摘要
Pulsed electric field (PEF) treatment was examined as a potential decontamination method for tissue engineering biomatrices by determining the susceptibility of a range of microorganisms whilst within a collagen gel. High intensity pulsed electric fields were applied to collagen gel biomatrices containing either Escherichia coli, Pseudomonas aeruginosa, Staphylococcus epidermidis, Candida albicans, Saccharomyces cerevisiae or the spores of Aspergillus niger. The results established varying degrees of microbial PEF susceptibility. When high initial cell densities (106–107 CFU ml−1) were PEF treated with 100 pulses at 45 kV cm−1, the greatest log reduction was achieved with S. cerevisiae (~6.5 log10 CFU ml−1) and the lowest reduction achieved with S. epidermidis (~0.5 log10 CFU ml−1). The results demonstrate that inactivation is influenced by the intrinsic properties of the microorganism treated. Further investigations are required to optimise the microbial inactivation kinetics associated with PEF treatment of collagen gel biomatrices.
引用
收藏
页码:507 / 515
页数:8
相关论文
共 115 条
[1]  
Drury JL(2003)Hydrogels for tissue engineering: scaffold design variables and applications Biomaterials 24 4337-4351
[2]  
Mooney DJ(2003)Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds Eur Cell Mater 5 29-40
[3]  
Sachlos E(2006)Treatment and prevention of Antimicrob Agents Chemother 50 3977-3983
[4]  
Czernuszka JT(2000)  J Infect Dis 181 1337-1349
[5]  
Kwakman PHS(2001) experimental biomaterial-associated infection by bactericidal peptide 2 Emerg Infect Dis 7 277-281
[6]  
Te Velde AA(2005)Biomaterial-associated persistence of Drugs 65 179-214
[7]  
Vandenbroucke-Grauls CMJE(2007)  Biomaterials 28 5148-5154
[8]  
Van Deventer SJH(1993) in pericatheter macrophages J Mater Sci Mater Med 4 40-49
[9]  
Zaat SAJ(2008)Biofilms and device-associated infections J Appl Microbiol 105 963-969
[10]  
Boelens JJ(2000)Infections associated with medical devices: pathogenesis, management and prophylaxis J Biomed Mater Res 49 448-459